Zobrazeno 1 - 3
of 3
pro vyhledávání: '"F Morneau-Jacob"'
Publikováno v:
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 48:S50-S50
Background: Rituximab is a B-cell-depleting monoclonal antibody whose off-label use is funded in Alberta by the Short-Term Exceptional Drug Therapy (STEDT) program. This study describes the use of rituximab for pediatric central nervous system (CNS)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::76912243d6dc54dd27c44f52a6726dc3
https://doi.org/10.1017/cjn.2021.387
https://doi.org/10.1017/cjn.2021.387
Autor:
F Morneau-Jacob, R Ogilvie
Publikováno v:
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 45:S24-S24
Background: Anti-NMDAR Encephalitis is an autoimmune disease of children and adults which most often presents with sub-acute psychiatric disturbance or seizures, but includes a broad group of potential clinical manifestations. Routine neuroimaging, s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e1e1143dae1f2e7e7d90ef59c673466
https://doi.org/10.1017/cjn.2018.132
https://doi.org/10.1017/cjn.2018.132
Autor:
Ng AC; University of Alberta, Edmonton, Canada., Kassiri J; University of Alberta, Edmonton, Canada., Goez HR; University of Alberta, Edmonton, Canada., Morneau-Jacob F; University of Alberta, Edmonton, Canada., Mailo J; University of Alberta, Edmonton, Canada.
Publikováno v:
Child neurology open [Child Neurol Open] 2022 Mar 24; Vol. 9, pp. 2329048X221083761. Date of Electronic Publication: 2022 Mar 24 (Print Publication: 2022).